7
Post-Cataract Surgery
Inflammation/Laser
Vision Correction
Key
Findings:
23% of ASCRS members
reported that 6% or more of
their
cataract patients experience
1+ cells/flare or greater 3–7 days
after surgery.
34% of ASCRS members do
not use any anti-inflammatories
(NSAIDs or steroids) for normal
cataract patients. However,
36% are using BOTH NSAIDs
and steroids 1 day postop.
Key Findings:
65% of ASCRS members use UCVA
of 20/20 or better as a standardized
way of assessing successful LVC
outcomes. 20% have no standard
assessment.
ASCRS members believe that
LASIK increases dry eye in 29%
of their patients 3 months after
surgery. This maintains at 30%,
6 months postop.
